<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-18</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-18</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>78</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>3</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
*   <strong>è‚ é“T-betâº Tr1ç»†èƒåœ¨é¥®é£Ÿä¿¡å·é©±åŠ¨ä¸‹ä¸»å¯¼å°è‚ å…ç–«</strong>ï¼Œæ­ç¤ºäº†é¥®é£Ÿä¸è‚ é“å…ç–«ç¨³æ€çš„æ–°æœºåˆ¶ã€‚<br />
*   <strong>Kdm4Cåœ¨KRASçªå˜çš„èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­æ˜¯è‡´ç™Œé©±åŠ¨åŸºå› </strong>ï¼Œå¹¶è°ƒæ§ERKæ´»æ€§ï¼Œä¸ºé¶å‘æ²»ç–—æä¾›æ–°æ€è·¯ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚ é“å…ç–«è°ƒæ§</strong>ï¼šç ”ç©¶é¥®é£Ÿä¿¡å·å¦‚ä½•å½±å“è‚ é“T-betâº Tr1ç»†èƒï¼ŒåŠå…¶åœ¨å°è‚ å…ç–«ä¸­çš„ä½œç”¨ã€‚<br />
*   <strong>è‚¿ç˜¤å…ç–«ä¸é¶å‘æ²»ç–—</strong>ï¼šæ¢ç´¢åµŒåˆæŠ—åŸå—ä½“ä»‹å¯¼çš„è‚¿ç˜¤æŠ—åŸæ‘„å–ä¸æ ‘çªçŠ¶ç»†èƒæ¿€æ´»ï¼Œä»¥åŠKdm4Cåœ¨èƒ°è…ºç™Œä¸­çš„è‡´ç™Œæœºåˆ¶ã€‚<br />
*   <strong>å¾®ç”Ÿç‰©ç»„ä¸ç–¾ç—…</strong>ï¼šè°ƒæŸ¥è‚ é“å’Œé˜´é“å¾®ç”Ÿç‰©ç»„åœ¨å­å®«å†…è†œç™Œä¸­çš„ä½œç”¨ï¼Œä»¥åŠè‚ é“å¾®ç”Ÿç‰©å¦‚ä½•ä¿ƒè¿›æ¯èƒç•Œé¢å…ç–«è€å—ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦è”åˆåˆ†æ</strong>ï¼šæ•´åˆRNA-seqã€ChIP-seqã€TCR-seqã€å…¨åŸºå› ç»„äºšç¡«é…¸æ°¢ç›æµ‹åºç­‰æŠ€æœ¯ï¼Œå…¨é¢è§£æç”Ÿç‰©å­¦è¿‡ç¨‹ã€‚<br />
*   <strong>ç©ºé—´è½¬å½•ç»„å­¦</strong>ï¼šåˆ©ç”¨10X ChromiumæŠ€æœ¯ç»˜åˆ¶ä¸‹ä¸˜è„‘ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å°„å›¾è°±ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p>
</blockquote>
<p>BRUIN 313/314 è¯•éªŒä¸ºéå…±ä»·å¸ƒé²é¡¿é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚ï¼ˆBTKiï¼‰ä½œä¸ºæ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ï¼ˆCLLï¼‰ä¸€çº¿æ²»ç–—å¼€è¾Ÿäº†æ–°é€”å¾„ï¼ŒBRUIN CLL-313 ä¸‰æœŸè¯•éªŒæ­£åœ¨è¯„ä¼°çš®æ‰˜å¸ƒæ›¿å°¼è”åˆè‹¯è¾¾è«å¸æ±€å’Œåˆ©å¦¥æ˜”å•æŠ—çš„ç–—æ•ˆã€‚</p>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p>
<ul>
<li><strong>å…ç–«ç–—æ³•è¯æ•ˆå­¦ä¸è”åˆç–—æ³•</strong>ï¼šæ¢ç´¢ Durvalumab å•ç‹¬åŠè”åˆ Tremelimumab/Bevacizumab æ²»ç–—ä¸å¯åˆ‡é™¤è‚ç»†èƒç™Œï¼ˆuHCCï¼‰çš„ T ç»†èƒå—ä½“ä¸å…ç–«åŸºå› è¡¨è¾¾ã€‚</li>
<li><strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šç ”ç©¶è„‚è´¨ä»£è°¢é‡ç¼–ç¨‹å¯¹è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆTMEï¼‰åŠå…ç–«ç»†èƒï¼ˆTILsã€DCã€å·¨å™¬ç»†èƒç­‰ï¼‰åŠŸèƒ½çš„å½±å“ï¼Œä»¥åŠåå™¬æ£€æŸ¥ç‚¹ï¼ˆå¦‚ Fc å—ä½“ã€MAC-1ã€SLAMF7ï¼‰åœ¨ç™Œç—‡å…ç–«æ²»ç–—ä¸­çš„ä½œç”¨ã€‚</li>
<li><strong>ctDNA ä¸é¢„åè¯„ä¼°</strong>ï¼šå¼€å‘è¶…çµæ• ctDNA åˆ†ææŠ€æœ¯ï¼Œç”¨äºé¢„æµ‹å®ä½“è‚¿ç˜¤æ‚£è€…æ¥å—å…ç–«ç–—æ³•ï¼ˆåŒ…æ‹¬ PD-1/L1 æŠ—ä½“ï¼‰çš„æ— è¿›å±•ç”Ÿå­˜æœŸï¼ˆPFSï¼‰å’Œæ€»ä½“ç”Ÿå­˜æœŸï¼ˆOSï¼‰ï¼Œä»¥åŠéªŒè¯å…¶åœ¨å¤§ B ç»†èƒæ·‹å·´ç˜¤ä¸€çº¿æ²»ç–—åçš„åº”ç”¨ã€‚</li>
</ul>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p>
<ul>
<li><strong>RNA ä¿®é¥°è°ƒæ§</strong>ï¼šN6-Methyladenosine (m6A) ä½œä¸ºç™Œç—‡ä¸­æ¢è°ƒæ§å› å­ï¼Œå½±å“è‚¿ç˜¤å‘ç”Ÿã€å…ç–«é€ƒé¿å’Œæ²»ç–—è€è¯æ€§ã€‚</li>
<li><strong>ä¸‰ç»´ç™Œç—‡æˆåƒ</strong>ï¼šå¹³è¡¡äºŒç»´ä¸ä¸‰ç»´æˆåƒï¼Œç»“åˆå¤šç»„å­¦é›†æˆå’Œè™šæ‹ŸæŸ“è‰²ï¼Œå…¨é¢è§£æè‚¿ç˜¤å¼‚è´¨æ€§ã€‚</li>
</ul>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ–°å‹ç”Ÿç‰©ä¿¡æ¯å­¦æ¡†æ¶é—®ä¸–ï¼Œå®ç°å•ç»†èƒé•¿è¯»é•¿æµ‹åºçš„å¼‚æ„ä½“çº§åˆ«åˆ†è¾¨ç‡ï¼Œä¸ºç†è§£ç»†èƒå¤šæ ·æ€§åŠç–¾ç—…æœºåˆ¶æä¾›æ–°è§†è§’ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- åˆ©ç”¨å•ç»†èƒé•¿è¯»é•¿æµ‹åºæ­ç¤ºå¼‚æ„ä½“å¤šæ ·æ€§ã€ç»†èƒç±»å‹ç‰¹å¼‚æ€§å‰ªæ¥åŠå…¶åœ¨å¥åº·ä¸ç–¾ç—…ä¸­çš„ä½œç”¨ã€‚<br />
- é€šè¿‡ä¼ªæ‰¹é‡ï¼ˆpseudobulkï¼‰æ–¹æ³•æ§åˆ¶å•ç»†èƒRNAæµ‹åºä¸­çš„å™ªå£°ï¼Œæå‡å·®å¼‚è¡¨è¾¾åˆ†æçš„å‡†ç¡®æ€§ã€‚<br />
- æ¢ç´¢é€šè¿‡å¹²æ‰°ç»†èŒé€šè®¯è€Œéç›´æ¥æ€ç­æ¥é¢„é˜²ç‰™å‘¨ç–¾ç—…çš„æ–°ç­–ç•¥ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é¦–æ¬¡å®ç°å•ç»†èƒé•¿è¯»é•¿æµ‹åºçš„å¼‚æ„ä½“çº§åˆ«åˆ†è¾¨ç‡ã€‚<br />
- æå‡ºæ–°å‹æ–¹æ³•ä»¥å¹²æ‰°ç»†èŒåŒ–å­¦ä¿¡å·ï¼Œå®ç°é€‰æ‹©æ€§è°ƒæ§ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (55æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE298394 å—é¥®é£Ÿä¿¡å·é©±åŠ¨çš„è‚ é“é©»ç•™T-betè¡¨è¾¾Tr1ç»†èƒä¸»å¯¼å°è‚ å…ç–«ç¯å¢ƒ IV</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Eduard Ansaldo ; Daniel Yong ; Nathan Carrillo ; Taryn McFadden ; Mahnoor Abid ; Dan Corral ; Claudia Rivera ; Taylor Farley ; Nicolas Bouladoux ; Inta Gribonika ; Yasmine BelkaidSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal immunity provides defense against enteric pathogens, mediates symbiotic relationships with the resident microbiota, and provides tolerance to food antigens, safeguarding critical nutrient absorption and barrier functions of this mucosal tissue. Despite the large abundance of tissue resident activated T cells, how T cell immunity contributes to these various roles remains poorly understood. Here we describe a previously uncharacterized dominant T-bet expressing Tr1 T cell population in the small intestine lamina propria present at homeostasis. Importantly, this IL-10 secreting CD4^+^T-bet^+^ T cell population appears in the small intestine at the time of weaning independently of the resident microbiota, presenting similar accumulation, functional capacity, and TCR repertoire in germ free conditions. Instead, small intestinal T-bet^+^ Tr1 T cells respond to dietary signals driving their accumulation, suppressive program, and clonal selection; and depend on cDC1s, IL-27 signaling, and T-bet, but not IL-12. Altogether, this work uncovers a previously unappreciated dominant player in homeostatic small intestinal immunity with the potential to play critical suppressive roles in oral tolerance to dietary antigens, raising important implications for the understanding of food allergy and celiac disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298394" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE298386 å—é¥®é£Ÿä¿¡å·é©±åŠ¨çš„è‚ é“é©»ç•™T-betè¡¨è¾¾Tr1ç»†èƒä¸»å¯¼å°è‚ å…ç–«ç¯å¢ƒ III</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Eduard Ansaldo ; Daniel Yong ; Nathan Carrillo ; Taryn McFadden ; Mahnoor Abid ; Dan Corral ; Claudia Rivera ; Taylor Farley ; Nicolas Bouladoux ; Inta Gribonika ; Yasmine BelkaidSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal immunity provides defense against enteric pathogens, mediates symbiotic relationships with the resident microbiota, and provides tolerance to food antigens, safeguarding critical nutrient absorption and barrier functions of this mucosal tissue. Despite the large abundance of tissue resident activated T cells, how T cell immunity contributes to these various roles remains poorly understood. Here we describe a previously uncharacterized dominant T-bet expressing Tr1 T cell population in the small intestine lamina propria present at homeostasis. Importantly, this IL-10 secreting CD4^+^T-bet^+^ T cell population appears in the small intestine at the time of weaning independently of the resident microbiota, presenting similar accumulation, functional capacity, and TCR repertoire in germ free conditions. Instead, small intestinal T-bet^+^ Tr1 T cells respond to dietary signals driving their accumulation, suppressive program, and clonal selection; and depend on cDC1s, IL-27 signaling, and T-bet, but not IL-12. Altogether, this work uncovers a previously unappreciated dominant player in homeostatic small intestinal immunity with the potential to play critical suppressive roles in oral tolerance to dietary antigens, raising important implications for the understanding of food allergy and celiac disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298386" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE298374 å—é¥®é£Ÿä¿¡å·é©±åŠ¨çš„è‚ é“é©»ç•™T-betè¡¨è¾¾Tr1ç»†èƒä¸»å¯¼å°è‚ å…ç–«ç¯å¢ƒ II</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Eduard Ansaldo ; Daniel Yong ; Nathan Carrillo ; Taryn McFadden ; Mahnoor Abid ; Dan Corral ; Claudia Rivera ; Taylor Farley ; Nicolas Bouladoux ; Inta Gribonika ; Yasmine BelkaidSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal immunity provides defense against enteric pathogens, mediates symbiotic relationships with the resident microbiota, and provides tolerance to food antigens, safeguarding critical nutrient absorption and barrier functions of this mucosal tissue. Despite the large abundance of tissue resident activated T cells, how T cell immunity contributes to these various roles remains poorly understood. Here we describe a previously uncharacterized dominant T-bet expressing Tr1 T cell population in the small intestine lamina propria present at homeostasis. Importantly, this IL-10 secreting CD4^+^T-bet^+^ T cell population appears in the small intestine at the time of weaning independently of the resident microbiota, presenting similar accumulation, functional capacity, and TCR repertoire in germ free conditions. Instead, small intestinal T-bet^+^ Tr1 T cells respond to dietary signals driving their accumulation, suppressive program, and clonal selection; and depend on cDC1s, IL-27 signaling, and T-bet, but not IL-12. Altogether, this work uncovers a previously unappreciated dominant player in homeostatic small intestinal immunity with the potential to play critical suppressive roles in oral tolerance to dietary antigens, raising important implications for the understanding of food allergy and celiac disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298374" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE298371 å—é¥®é£Ÿä¿¡å·é©±åŠ¨çš„è‚ é“é©»ç•™T-betè¡¨è¾¾Tr1ç»†èƒä¸»å¯¼å°è‚ å…ç–«ç¯å¢ƒ I</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Eduard Ansaldo ; Daniel Yong ; Nathan Carrillo ; Taryn McFadden ; Mahnoor Abid ; Dan Corral ; Claudia Rivera ; Taylor Farley ; Nicolas Bouladoux ; Inta Gribonika ; Yasmine BelkaidSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusIntestinal immunity provides defense against enteric pathogens, mediates symbiotic relationships with the resident microbiota, and provides tolerance to food antigens, safeguarding critical nutrient absorption and barrier functions of this mucosal tissue. Despite the large abundance of tissue resident activated T cells, how T cell immunity contributes to these various roles remains poorly understood. Here we describe a previously uncharacterized dominant T-bet expressing Tr1 T cell population in the small intestine lamina propria present at homeostasis. Importantly, this IL-10 secreting CD4^+^T-bet^+^ T cell population appears in the small intestine at the time of weaning independently of the resident microbiota, presenting similar accumulation, functional capacity, and TCR repertoire in germ free conditions. Instead, small intestinal T-bet^+^ Tr1 T cells respond to dietary signals driving their accumulation, suppressive program, and clonal selection; and depend on cDC1s, IL-27 signaling, and T-bet, but not IL-12. Altogether, this work uncovers a previously unappreciated dominant player in homeostatic small intestinal immunity with the potential to play critical suppressive roles in oral tolerance to dietary antigens, raising important implications for the understanding of food allergy and celiac disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298371" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE293372 åµŒåˆæŠ—åŸå—ä½“åè°ƒè‚¿ç˜¤æŠ—åŸæ‘„å–å’Œæ ‘çªçŠ¶ç»†èƒæ´»åŒ–ã€‚[RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€dendritic cellã€antigenã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nadine Fournier ; Yahya Mohammadzadeh ; Michele De PalmaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusEffective anti-tumor immunity requires dendritic cells (DCs) to internalize, process and present tumor antigens to T cells. Adoptive transfer of DCs loaded ex vivo with tumor antigens has been shown to stimulate anti-tumor immunity in patients with cancer, but clinical responses have been mixed. To address limitations of traditional DC-based therapies, we constructed and functionally screened a panel of chimeric antigen receptors (CARs) optimized for expression and activity in DCs. Through this screening, we identified key functional components that informed the design of an inducible platform centered on an instructive chimeric antigen receptor (iCAR). This platform enables the DCs to (i) recognize a surface molecule present on cancer cells or their extracellular vesicles (EVs), such as GD2 and HER2, thereby promoting the acquisition of tumor-derived material that contains putative tumor antigens; (ii) undergo immunostimulatory activation to prime antigen-specific T cells via both cross-dressing and cross-presentation; and (iii) transactivate the expression of a therapeutic gene (IL-12) in response to antigen uptake. The iCAR converted melanoma-derived EVs from immune-suppressive to stimulatory cues for DCs. Moreover, systemic administration of iCAR-DCs enhanced antigen-specific T cells, expanded low-frequency T cell clonotypes, and delayed tumor growth in immunotherapy-resistant melanoma models without the need for ex vivo antigen loading or cell maturation. iCAR-DCs provide a platform for antigen-agnostic cancer immunotherapy that integrates antigen uptake with programmable DC activation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293372" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE305725 å¡ç½—è±çº³å­å®«å†…è†œç™Œæ‚£è€…çš„é˜´é“å’Œè‚ é“å¾®ç”Ÿç‰©ç»„è¯•ç‚¹ç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hazel B Nichols ; Mu JinSeries Type : OtherOrganism : metagenomeCharacterization of the microbiome in vaginal and stool samples self-sampled from endometrial cancer survivors enrolled in the Carolina Endometrial Cancer Study.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305725" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE300199 èµ–æ°¨é…¸å»ç”²åŸºé…¶ Kdm4C æ˜¯ä¸€ç§è‡´ç™Œé©±åŠ¨å› å­ï¼Œå¹¶è°ƒèŠ‚ KRAS çªå˜èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­çš„ ERK æ´»æ€§ [ChIP-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€ChIP-seqã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Mennatallah Shaheen ; Sarah Dhebat ; Kimal I Rajapakshe ; Bidyut Ghosh ; Benson C Selvanesan ; Shariq Ansari ; Cara Haymaker ; Dorsay Sadeghian ; Huamin Wang ; Haoqiang Ying ; Anirban MaitraSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensDeregulation of proteins involved in chromatin regulation is common in pancreatic ductal adenocarcinoma (PDAC). Lysine demethylase 4C (Kdm4C) is one of the chromatin-modifying proteins frequently overexpressed across multiple solid cancers and is linked to chromatin instability, increased cell proliferation, and enhanced stem cell-like behavior. We observed upregulation of Kdm4C protein in a panel of human PDAC cell lines and patient samples compared to non-neoplastic controls. CRISPR/Cas9-mediated deletion of KDM4C in human and murine PDAC cells reduced proliferation, clonogenicity and increased survival of orthotopically implanted murine PDAC allografts. Transcriptomic and proteomics analyses revealed that loss of Kdm4C in both human and murine PDAC cell lines was associated with reduction of activated phospho-Erk, a pivotal effector downstream of mutant Ras. Using proximity labeling, we identified the histone deacetylase SIRT1 as a novel interacting protein with Kdm4C via the latterâ€™s Tudor reader domain. SIRT1-mediated deacetylation leads to repression of downstream targets, including the dual specificity phosphatase DUSP2, which is known to inactivate Erk via dephosphorylation. In vitro propagation of KDM4C-null PDAC lines eventually led to adaptation and restitution of Erk signaling via compensatory upregulation of other KDM4 family members. To bypass this genetic compensation, we tested a preclinical pan-KDM4 inhibitor TACH107 and confirmed its efficacy in in vitro and in vivo PDAC models including those resistant to the covalent KRASG12D inhibitor MTRX1133. Our studies identify Kdm4C as an oncogenic molecule that sustains Erk signaling in KRAS-mutant PDAC and can be broadly targeted via small molecule inhibitors.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300199" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE300083 èµ–æ°¨é…¸å»ç”²åŸºé…¶ Kdm4C æ˜¯ä¸€ç§è‡´ç™Œé©±åŠ¨å› å­ï¼Œå¹¶è°ƒèŠ‚ KRAS çªå˜èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­çš„ ERK æ´»æ€§ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šregex:onco(logy|logist|gene|genic)ã€RNA-seqã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Mennatallah Shaheen ; Sarah Dhebat ; Kimal I Rajapakshe ; Bidyut Ghosh ; Benson C Selvanesan ; Shariq Ansari ; Cara Haymaker ; Dorsay Sadeghian ; Huamin Wang ; Haoqiang Ying ; Anirban MaitraSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDeregulation of proteins involved in chromatin regulation is common in pancreatic ductal adenocarcinoma (PDAC). Lysine demethylase 4C (Kdm4C) is one of the chromatin-modifying proteins frequently overexpressed across multiple solid cancers and is linked to chromatin instability, increased cell proliferation, and enhanced stem cell-like behavior. We observed upregulation of Kdm4C protein in a panel of human PDAC cell lines and patient samples compared to non-neoplastic controls. CRISPR/Cas9-mediated deletion of KDM4C in human and murine PDAC cells reduced proliferation, clonogenicity and increased survival of orthotopically implanted murine PDAC allografts. Transcriptomic and proteomics analyses revealed that loss of Kdm4C in both human and murine PDAC cell lines was associated with reduction of activated phospho-Erk, a pivotal effector downstream of mutant Ras. Using proximity labeling, we identified the histone deacetylase SIRT1 as a novel interacting protein with Kdm4C via the latterâ€™s Tudor reader domain. SIRT1-mediated deacetylation leads to repression of downstream targets, including the dual specificity phosphatase DUSP2, which is known to inactivate Erk via dephosphorylation. In vitro propagation of KDM4C-null PDAC lines eventually led to adaptation and restitution of Erk signaling via compensatory upregulation of other KDM4 family members. To bypass this genetic compensation, we tested a preclinical pan-KDM4 inhibitor TACH107 and confirmed its efficacy in in vitro and in vivo PDAC models including those resistant to the covalent KRASG12D inhibitor MTRX1133. Our studies identify Kdm4C as an oncogenic molecule that sustains Erk signaling in KRAS-mutant PDAC and can be broadly targeted via small molecule inhibitors.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300083" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE310031 è‚ é“èŒç¾¤ä¿ƒè¿›æ¯èƒç•Œé¢å…ç–«è€å—</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Julia A Brown ; Mohammed Amir ; Shui Yu ; Daniel S Wong ; Jinghua Gu ; Uthra Balaji ; Christopher Parkhurst ; Seunghee Hong ; Lucy R Hart ; Hannah C Carrow ; Mamadou Bah ; Aparna Ananthanarayanan ; Katherine Z Sanidad ; Mengze Lyu ; Anisa Siddikova ; Marina Lima Silva Santos ; Inna Serganova ; Gretchen E Diehl ; Josef Anrather ; Naohiro Inohara ; Gregory F Sonnenberg ; Virginia Pascual ; Melody Y ZengSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusImmune tolerance at the maternal-fetal interface is required for fetal development. Excessive maternal interferon gamma (IFNÎ³) and interleukin-17 (IL-17) is linked to pregnancy complications, but the regulation of maternal IFNÎ³ and IL-17 at the maternal-fetal interface (MFI) is poorly understood. Here we demonstrate a gut-placenta immune axis in pregnant mice in which the absence or perturbation of gut microbiota dysregulates maternal IFNÎ³ and IL-17 responses at the MFI, resulting in fetal resorption. Microbiota-dependent tryptophan derivatives suppress IFNÎ³+ and IL-17+ T cells at the MFI by priming myeloid-derived suppressor cells (MDSCs) and gut-derived RORÎ³t+ Tregs, respectively. The tryptophan derivative indole-3-carbinol, or tryptophan-metabolizing Lactobacillus murinus, rebalances the T cell response at the MFI and reduces fetal resorption in germ-free mice. Furthermore, MDSCs, RORÎ³t+ Tregs, and microbiota-dependent tryptophan derivatives are dysregulated at the MFI in human recurrent miscarriage cases. Together, our findings identify microbiota-dependent immune tolerance mechanisms that promote fetal development.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310031" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE293373 åµŒåˆæŠ—åŸå—ä½“åè°ƒè‚¿ç˜¤æŠ—åŸæ‘„å–å’Œæ ‘çªçŠ¶ç»†èƒæ´»åŒ–ã€‚[TCR-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€dendritic cellã€antigen<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nadine Fournier ; Rachel Marcone ; Yahya Mohammadzadeh ; Michele De PalmaSeries Type : OtherOrganism : Mus musculusEffective anti-tumor immunity requires dendritic cells (DCs) to internalize, process and present tumor antigens to T cells. Adoptive transfer of DCs loaded ex vivo with tumor antigens has been shown to stimulate anti-tumor immunity in patients with cancer, but clinical responses have been mixed. To address limitations of traditional DC-based therapies, we constructed and functionally screened a panel of chimeric antigen receptors (CARs) optimized for expression and activity in DCs. Through this screening, we identified key functional components that informed the design of an inducible platform centered on an instructive chimeric antigen receptor (iCAR). This platform enables the DCs to (i) recognize a surface molecule present on cancer cells or their extracellular vesicles (EVs), such as GD2 and HER2, thereby promoting the acquisition of tumor-derived material that contains putative tumor antigens; (ii) undergo immunostimulatory activation to prime antigen-specific T cells via both cross-dressing and cross-presentation; and (iii) transactivate the expression of a therapeutic gene (IL-12) in response to antigen uptake. The iCAR converted melanoma-derived EVs from immune-suppressive to stimulatory cues for DCs. Moreover, systemic administration of iCAR-DCs enhanced antigen-specific T cells, expanded low-frequency T cell clonotypes, and delayed tumor growth in immunotherapy-resistant melanoma models without the need for ex vivo antigen loading or cell maturation. iCAR-DCs provide a platform for antigen-agnostic cancer immunotherapy that integrates antigen uptake with programmable DC activation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293373" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 45 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (19æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>Durvalumab å•ç‹¬åŠä¸ Tremelimumab æˆ– Bevacizumab è”åˆæ²»ç–—ä¸å¯åˆ‡é™¤è‚ç»†èƒç™Œçš„ T ç»†èƒå—ä½“ä¸å…ç–«åŸºå› è¡¨è¾¾è¯æ•ˆå­¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒã€Bç»†èƒã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šåœ¨ I/II æœŸç¬¬ 22ï¼ˆNCT02519348ï¼‰è¯•éªŒä¸­ï¼ŒSTRIDEï¼ˆå•æ¬¡ç‰¹é›·ç¾å•æŠ—å¸¸è§„é—´æœŸ Durvalumabï¼‰çš„å®¢è§‚ç¼“è§£ç‡ä¸º 24.0%ï¼Œdurvalumab åŠ  bevacizumabï¼ˆD+Bï¼‰21.3%ï¼Œdurvalumabï¼ˆDï¼‰å•ç”¨æ²»ç–—ä¸º 11.5%ï¼Œé€‚ç”¨äºä¸å¯åˆ‡é™¤è‚ç»†èƒç™Œï¼ˆuHCCï¼‰ã€‚å¢æ®–ç‡å¢åŠ çš„ CD8+ T ç»†èƒä¸ STRIDE å•ç”¨æ²»ç–—ç›¸æ¯” D å•ç”¨æ²»ç–—çš„ç–—æ•ˆæå‡ç›¸å…³ã€‚æœ¬ç ”ç©¶åˆ†æäº†å¤–å‘¨è¡€ä¸­ T ç»†èƒå…‹éš†æ‰©å¢å’ŒåŸºå› è¡¨è¾¾ç‰¹å¾ï¼ˆGESï¼‰çš„å˜åŒ–ï¼Œä»¥æ¢è®¨ STRIDE å’Œ D+B å•ç”¨æ²»ç–—æŠ—ç™Œæ´»æ€§çš„ä½œç”¨æœºåˆ¶ã€‚æ‚£è€…åŠæ–¹æ³•ï¼šç»„ç»„å‚ä¸è€…ä¸º uHCC ä¸”æ— å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚æ²»ç–—çš„å‚ä¸è€…ã€‚ä»åŸºçº¿åŠç¬¬ä¸€è½®æ²»ç–—å‘¨æœŸç»“æŸæ—¶é‡‡é›†çš„å¤–å‘¨è¡€ä¸­åˆ†ç¦»å‡º DNA å’Œ RNAã€‚æµ‹é‡äº†æ²»ç–—ç»„é—´ T ç»†èƒå…‹éš†æ€§å’Œ GES åŸºçº¿å€¼åŠåŸºçº¿å˜åŒ–ï¼Œå¹¶è¯„ä¼°äº†ä¸æ”¾å°„å­¦ååº”çš„å…³è”ã€‚ç»“æœï¼šæ²»ç–—ç»„é—´ T ç»†èƒçš„åŸºçº¿ä¸°å¯Œåº¦æˆ–è¾›æ™®æ£®å…‹éš†æ€§æ–¹é¢æ— æ˜¾è‘—å·®å¼‚ã€‚STRIDE<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998467552487395328/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>è„‚è´¨ä»£è°¢é‡ç¼–ç¨‹åœ¨å¡‘é€ è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒä¸­çš„å¤šé‡ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€ä»£è°¢<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è„‚è´¨ä»£è°¢é‡ç¼–ç¨‹è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆTMEï¼‰ï¼Œå¹¶æ”¹å˜å…ç–«ç»†èƒçš„åŠŸèƒ½ï¼ŒåŒ…æ‹¬è‚¿ç˜¤æµ¸æ¶¦æ·‹å·´ç»†èƒï¼ˆTILsï¼‰ã€‚è™½ç„¶è„‚è´¨å¯ä»¥å¢å¼ºæ•´ä½“ T ç»†èƒæ´»æ€§ï¼Œä½† TME ä¸­é«˜è„‚è´¨å«é‡å¯èƒ½æŠ‘åˆ¶æ•ˆåº” T ç»†èƒçš„æŠ—è‚¿ç˜¤åŠŸèƒ½ï¼Œå¹¶å¢å¼ºè°ƒæ§ T ç»†èƒçš„å…ç–«æŠ‘åˆ¶ä½œç”¨ã€‚æ­¤å¤–ï¼Œè„‚è´¨ä»£è°¢é‡ç¼–ç¨‹æå¤§å½±å“ TILs ä¸ TME ä¸­å…¶ä»–å…ç–«ç»†èƒä¹‹é—´çš„äº¤äº’ä½œç”¨ï¼ŒåŒ…æ‹¬æ ‘çªçŠ¶ç»†èƒã€å·¨å™¬ç»†èƒå’Œéª¨é«“ç³»æ¥æºçš„æŠ‘åˆ¶ç»†èƒã€‚é€šè¿‡è®¨è®ºé’ˆå¯¹ TILs è„‚è´¨ä»£è°¢çš„æ½œåœ¨æ²»ç–—ç­–ç•¥ï¼Œä»¥åŠåŒ–ç–—å…ç–«ç–—æ³•ã€çº³ç±³åŒ»å­¦å’Œé‡‡çº³ç»†èƒç§»æ¤ç–—æ³•çš„è”åˆæ–¹æ³•ï¼Œæˆ‘ä»¬æ—¨åœ¨ä¸ºç™Œç—‡æ‚£è€…æœ‰æ•ˆæ²»ç–—çš„æ¨è¿›å¥ å®šåŸºç¡€ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/2000685091408494592/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>BRUIN 313 å’Œ 314 è¯•éªŒä¸ºéå…±ä»·å¸ƒé²é¡¿é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶ä½œä¸ºæ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…çš„åˆå§‹æ²»ç–—æ‰“å¼€äº†å¤§é—¨ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæ·‹å·´ã€Bç»†èƒã€æ¿€é…¶<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998511550270787584/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>BRUIN CLL-313ï¼šçš®æ‰˜å¸ƒæ›¿å°¼ä¸è‹¯è¾¾è«å¸æ±€åŠ åˆ©å¦¥æ˜”å•æŠ—åœ¨æœªæ²»ç–—æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤æ‚£è€…ä¸­çš„éšæœº III æœŸè¯•éªŒã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæ·‹å·´ã€Bç»†èƒã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ BRUIN CLL-313 æ˜¯ä¸€é¡¹éšæœºã€å¼€æ”¾æ ‡ç­¾ã€å…¨çƒä¸‰æœŸä¸´åºŠè¯•éªŒï¼Œæ¯”è¾ƒäº†é«˜é€‰æ‹©æ€§éå…±ä»·å¸ƒé²æ›¿å°¼ï¼ˆBTKiï¼‰ä¸è‹¯è¾¾è«å¸æ±€åŠ åˆ©å¦¥æ˜”å•æŠ—ï¼ˆBendamustine plus rituximabï¼Œä¸€ç§å¸¸è§çš„ä¸€çº¿åŒ–ç–—å…ç–«ç–—æ³•ï¼‰åœ¨æ²»ç–—ç»éªŒæœªå—çš„æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤ï¼ˆCLL/SLLï¼‰æ‚£è€…ä¸­çš„ç–—æ•ˆå’Œå®‰å…¨æ€§ã€‚æ–¹æ³• æœªæ²»ç–— CLL/SLL ä¸”æ—  delï¼ˆ17pï¼‰çš„æ‚£è€…è¢«éšæœº 1ï¼š1 éšæœºåˆ†é…ä¸ºæŒç»­å¡æ‰˜å¸ƒé²æ›¿å°¼å•ç”¨è¯ç‰©æˆ– BendaRï¼ŒæŒ‰å…ç–«çƒè›‹ç™½é‡é“¾åŸºå› çªå˜çŠ¶æ€å’Œ Rai åˆ†å±‚ã€‚ä¸»è¦ç»ˆç‚¹ä¸ºç‹¬ç«‹è¯„å®¡å§”å‘˜ä¼šï¼ˆIRCï¼‰è¯„ä¼°çš„æ— è¿›å±•ç”Ÿå­˜æœŸï¼ˆPFSï¼‰;æ¬¡è¦ç»ˆç‚¹åŒ…æ‹¬æ€»ä½“ç”Ÿå­˜æœŸï¼ˆOSï¼‰ã€ç ”ç©¶è€…è¯„ä¼°çš„ PFSã€å®‰å…¨æ€§å’Œè€å—æ€§ã€‚ç»“æœæ€»ä½“è€Œè¨€ï¼Œ282 åæ‚£è€…è¢«éšæœºåˆ†é…æ¥å—å¡æ‰˜å¸ƒé²æ›¿å°¼ï¼ˆn=141ï¼‰æˆ–è‹¯è¾¾ Rï¼ˆn=141ï¼‰ã€‚IRC è¯„ä¼°çš„ PFS åœ¨å¡å¸ƒé²æ›¿å°¼ä¸ BendaR æ²»ç–—ä¸‹æ˜¾è‘—æ”¹å–„ï¼ˆé£é™©æ¯”[HR]ï¼Œ0<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998511565026349056/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>å¤§ B ç»†èƒæ·‹å·´ç˜¤ä¸€çº¿æ²»ç–—åå¾ªç¯è‚¿ç˜¤ DNA å¯æµ‹é‡æ®‹ç•™ç–¾ç—…çš„å‰ç»æ€§éªŒè¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€æ·‹å·´ã€Bç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ä¸´åºŠè‚¿ç˜¤å­¦æ‚å¿—ï¼Œå°åˆ·å‰ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1999963824728489984/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>é’ˆå¯¹ç™Œç—‡å…ç–«æ²»ç–—çš„åå™¬æ£€æŸ¥ç‚¹ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€å…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å·¨å™¬ç»†èƒé€šè¿‡åå™¬ä½œç”¨æ¶ˆç­ç™Œç»†èƒçš„èƒ½åŠ›å—åˆ°ä¿ƒåå™¬å’ŒæŠ‘åˆ¶æ€§åå™¬å—ä½“çš„ä¸¥æ ¼æ§åˆ¶ã€‚ä¿ƒåå™¬å—ä½“å¦‚ Fc å—ä½“ã€å·¨å™¬ç»†èƒ 1 æŠ—åŸï¼ˆMAC-1;ä¹Ÿç§°ä¸º CD11b/CD18ï¼‰å’Œä¿¡å·ä¼ å¯¼æ·‹å·´ç»†èƒæ¿€æ´»åˆ†å­å®¶æ—æˆå‘˜ 7ï¼ˆSLAMF7ï¼‰å·²è¢«è¯æ˜åœ¨ä¸´åºŠå‰æ¨¡å‹ä¸­ä¿ƒè¿›è‚¿ç˜¤ç»†èƒçš„æ¶ˆé™¤ï¼Œè€Œ Fc å—ä½“å·²è¢«è®¤å®šå¯¹ä¸´åºŠä¸Šå¤šç§å•å…‹éš†æŠ—ä½“çš„æŠ—è‚¿ç˜¤ç–—æ•ˆè‡³å…³é‡è¦ã€‚ä¸´åºŠå‰å’Œæ—©æœŸä¸´åºŠç ”ç©¶è¿˜å¼ºè°ƒï¼Œé˜»æ–­æŠ‘åˆ¶æ€§åå™¬æ£€æŸ¥ç‚¹ï¼Œå°¤å…¶æ˜¯ä¿¡å·è°ƒæ§è›‹ç™½Î±ï¼ˆSIRPÎ±ï¼‰åŠå…¶é…ä½“ CD47ï¼Œæ˜¯ç™Œç—‡æ²»ç–—çš„æœ‰å‰æ™¯æ–¹æ³•ã€‚ç„¶è€Œï¼Œè¿‘æœŸä¸´åºŠè¯•éªŒä¸­å¯¹æœ‰é™ç–—æ•ˆå’Œæ¯’æ€§çš„æ‹…å¿§å¯¼è‡´å¯¹è¯¥æ–¹æ³•çš„çƒ­æƒ…å‡å¼±ã€‚æœ¬ç»¼è¿°æ¢è®¨äº†æ”¯æŒåå™¬æ£€æŸ¥ç‚¹ä½œä¸ºç™Œç—‡æ²»ç–—é¶ç‚¹çš„è¯æ®ï¼ŒåŒæ—¶å¼ºè°ƒäº†è¯¥æ²»ç–—ç­–ç•¥å½“å‰é¢ä¸´çš„æŒ‘æˆ˜ã€‚æˆ‘ä»¬è¿˜æå‡ºäº†æå‡è¯¥æ–¹æ³•åœ¨æœªæ¥å·¥ä½œä¸­æœ‰æ•ˆæ€§å’Œå®‰å…¨æ€§çš„å»ºè®®ã€‚<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998508550542315520/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>å…³æ³¨è¡¨è¾¾ï¼šä½å‰‚è…ºç—…æ¯’ä»‹å¯¼å•çº¯ç–±ç–¹ç—…æ¯’èƒ¸è‹·æ¿€é…¶ç»™è¯å¯æ”¹å–„æ™šæœŸè‚ç»†èƒç™Œæ‚£è€…çš„è‚ç§»æ¤æ•ˆæœã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæ¿€é…¶ã€å•ç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/2000681039652110336/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>Drp1 ä¸ BIP çš„ç›¸äº’ä½œç”¨ç»´æŒçº¿ç²’ä½“åŠ¨æ€å¹³è¡¡ï¼Œä¿ƒè¿›é¼»å’½ç™Œä¸­ Anoikis çš„è€è¯æ€§å’Œè½¬ç§»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šçº¿ç²’ä½“ã€è€è¯<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: Anoikis è€è¯æ€§æ˜¯æŒ‡ç»†èƒåœ¨é”šå›ºæ— å…³æ¡ä»¶ä¸‹å­˜æ´»çš„ç°è±¡ï¼Œè¿™å¯¹ç™Œç»†èƒçš„ä¼ æ’­å’Œè½¬ç§»è‡³å…³é‡è¦ã€‚ä¸ºå¯»æ‰¾å…‹æœ anoikis è€è¯æ€§çš„ç­–ç•¥ï¼Œæˆ‘ä»¬é‡‡ç”¨äº†ç»“åˆè›‹ç™½è´¨ç»„ç­›é€‰çš„ 3D æ‚¬æµ®åŸ¹å…»æ¨¡å‹ï¼Œå‘ç°äº†ç±»ä¼¼ dynamin çš„è›‹ç™½ Drp1 ä¸é¼»å’½ç™Œï¼ˆNPCï¼‰ä¸­ anoikis è€è¯æ€§çš„å…³ç³»ã€‚Drp1 é€šè¿‡è°ƒæ§è£‚å˜å’Œçº¿ç²’ä½“åå™¬ï¼Œä¿ƒè¿›æ–°çº¿ç²’ä½“çš„ç”Ÿæˆå’ŒæŸä¼¤çº¿ç²’ä½“çš„æ¸…é™¤ï¼Œä»è€Œä½¿è‚¿ç˜¤ç»†èƒèƒ½å¤Ÿå…‹æœå¼‚çœ¼ä½“ã€‚æ­¤å¤–ï¼Œåœ¨é˜¿è¯ºä¼ŠåŸºæ–¯è€è¯æ€§æœŸé—´ï¼ŒDrp1 ä¸ BIP çš„ç›¸äº’ä½œç”¨å¢å¼ºï¼Œè¿™ä¿ƒè¿›äº†çº¿ç²’ä½“ç›¸å…³å†…è´¨ç½‘è†œï¼ˆMAMsï¼‰çš„å½¢æˆï¼Œä»¥ç»´æŒçº¿ç²’ä½“åŠ¨æ€å¹³è¡¡ã€‚ä»æœºåˆ¶ä¸Šçœ‹ï¼ŒCaMKKÎ²é€šè¿‡ O-GlcNAcylation ä¿®é¥°æ¿€æ´» AMPK-MFF-Drp1 å’Œ AMPK-mTOR-Drp1 é€šè·¯ï¼Œä»è€Œæ‹›å‹Ÿ Drp1 åˆ° MAMs ä¸­ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼ŒDrp1-BIP å¤åˆç‰©ä½œä¸º NPC ä¸´åºŠç»“å±€å’Œè½¬ç§»é£é™©çš„é¢„åæŒ‡æ ‡ã€‚ç»¼åˆæ¥çœ‹ï¼Œè¿™äº›ç»“æœé˜æ˜äº†<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/2000685086111088640/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>å¯¹å…ç–«ç–—æ³•æ²»ç–—å®ä½“è‚¿ç˜¤ä¸­ ctDNA åŠ¨æ€çš„è¶…çµæ•åˆ†æçš„å¹¿æ³›åº”ç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šå…ˆå‰ç ”ç©¶è¡¨æ˜ï¼Œè¡€æµ†æ¥æº ctDNA åœ¨æ¥å—å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚æ²»ç–—çš„ç™Œç—‡æ‚£è€…ä¸­å…·æœ‰ç”Ÿç‰©æ ‡å¿—ç‰©æ½œåŠ›ã€‚æœ¬ç ”ç©¶æ¢è®¨äº† ctDNA åœ¨æ¥å—å…ç–«ç–—æ³•æ²»ç–—çš„æ™šæœŸç™Œç—‡æ‚£è€…é˜Ÿåˆ—ä¸­é¢„æµ‹æ— è¿›å±•å’Œæ€»ä½“ç”Ÿå­˜çš„èƒ½åŠ›ã€‚å®éªŒè®¾è®¡ï¼šä¸ºäº†è¡¨å¾è¶…çµæ€§ ctDNA æ£€æµ‹åœ¨è¿™äº›æ‚£è€…ç®¡ç†ä¸­çš„æ½œåœ¨ä½œç”¨ï¼Œæˆ‘ä»¬è¿›è¡Œäº†è‚¿ç˜¤å…¨åŸºå› ç»„æµ‹åºâ€”â€”çŸ¥æƒ…çš„è¶…çµæ• ctDNA åˆ†æâ€”â€”åœ¨å›é¡¾æ€§é˜Ÿåˆ—ï¼ˆn=136ï¼‰å’Œå‰ç»æ€§éªŒè¯é˜Ÿåˆ—ï¼ˆn=66ï¼‰ä¸­ï¼Œæ¶µç›– 24 ç§ç™Œç—‡ç±»å‹ï¼Œå‡ä»…ä½¿ç”¨å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚æˆ–åŒç‰¹å¼‚æ€§æŠ—ä½“æˆ–å…ç–«æ€§å…ç–«è¯ç‰©æ²»ç–—ç»†èƒè”åŠ¨è€…ã€‚ç»“æœï¼šåˆ†æ 1455 ä¸ªçºµå‘æ ·æœ¬ï¼Œæˆ‘ä»¬å‘ç° ctDNA åˆ†å­ååº”åœ¨æ²»ç–—å¼€å§‹å 3 å‘¨å†…æµ‹é‡ï¼Œä¸æ— è¿›å±•æœŸå’Œæ€»ä½“ç”Ÿå­˜æœŸçš„æ”¹å–„ç›¸å…³ï¼Œè€Œä»»ä½•æ—¶å€™çš„ ctDNA æ¸…é™¤ç‡ä¸æ”¾å°„ååº”å’Œå»¶é•¿ç”Ÿå­˜æœŸé«˜åº¦ç›¸å…³ã€‚æ­¤å¤–ï¼ŒctDNA åŠ¨åŠ›å­¦åŒºåˆ†äº†çœŸå®è¿›å±•ä¸ä¼ªè¿›å±•ï¼Œå¹¶é¢„æµ‹äº†æ¥å—åˆæœŸè¿›å±•åæŒç»­å…ç–«æ²»ç–—æ‚£è€…çš„ç»“å±€ã€‚ç»“è®ºï¼šæœ¬ç ”ç©¶å¼ºè°ƒäº†è¶…æ•æ„Ÿ ctDNA<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/2000978306707668992/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>æ¥å— PD-1/L1 æŠ—ä½“åŠè”åˆæŠ—ç—…æ¯’é¢„é˜²è¯ç‰©æ²»ç–—çš„è‚ç»†èƒç™Œæ‚£è€… HBV å†æ´»åŒ–ï¼šå‰ç»æ€§è§‚å¯Ÿæ€§ç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæŠ—ä½“<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ï¼šè‚ç»†èƒç™Œï¼ˆHCCï¼‰ä¸­å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚ï¼ˆICIsï¼‰ç›¸å…³è¯•éªŒå›  HBV å†æ´»åŒ–å¯¹ HBV DNA è´Ÿè·æœ‰ä¸¥æ ¼é™åˆ¶ã€‚æœ¬ç ”ç©¶æ—¨åœ¨æ¯”è¾ƒæ¥å— ICI å’ŒæŠ—ç—…æ¯’æ²»ç–—çš„ä½æˆ–é«˜ HBV DNA è´Ÿè· HCC æ‚£è€…çš„ HBV å†æ´»åŒ–æƒ…å†µã€‚æ‚£è€…ä¸æ–¹æ³•ï¼šæœ¬å‰ç»æ€§è§‚å¯Ÿæ€§ç ”ç©¶ï¼ˆNCT04680598ï¼‰æ‹›å‹Ÿäº†æ¥å—è”åˆæŠ—ç—…æ¯’æ²»ç–—å¹¶è¿›è¡Œ ICI æ²»ç–—çš„ HBsAg é˜³æ€§ HCC æ‚£è€…ã€‚å‚ä¸è€…è¢«åˆ†ä¸º HBV DNA ä½ç»„ï¼ˆâ‰¤500 IU/mlï¼‰ç»„å’Œ HBV DNA é«˜ç»„ï¼ˆ&gt; 500 IU/ml ç»„ï¼‰ã€‚ä¸»è¦ç»ˆç‚¹æ˜¯ HBV çš„å†æ¿€æ´»ç‡ã€‚ç»“æœï¼š2020 å¹´ 12 æœˆ 25 æ—¥è‡³ 2024 å¹´ 2 æœˆ 23 æ—¥æœŸé—´ï¼Œ356 è‡³ 659 åå‚ä¸è€…è¢«åˆ†ç»„ä¸º HBV DNA ä½ç»„å’Œé«˜ç»„ã€‚HBV DNA é«˜ç»„ä¸­ï¼ŒHBeAg é˜³æ€§æ‚£è€…æ¯”ä¾‹æ˜¾è‘—è¾ƒé«˜ï¼ˆ24.1%å¯¹ 7.0%ï¼Œp &lt; 0.001ï¼‰ã€ALBI ç­‰çº§ 2-3ï¼ˆ49.9%å¯¹ 33.7%ï¼Œp<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998467569163948032/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 9 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æœŸåˆŠæ–‡ç« ">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>ç”¨äºå•ç»†èƒé•¿è¯»é•¿æµ‹åºçš„ç”Ÿç‰©ä¿¡æ¯å­¦æ¡†æ¶ï¼šè§£é”å¼‚æ„ä½“æ°´å¹³åˆ†è¾¨ç‡</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€bioinformatics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šNew long-read RNA sequencing methods capture full-length transcripts at single-cell resolution, revealing isoform diversity, cell-type specific splicing and roles in health and disease...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/bioinformatics-frameworks-for-single-cell-long-read-sequencing-unlocking-isoform-level-resolution/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>åˆ©ç”¨ä¼ªæ‰¹é‡æ–¹æ³•æ§åˆ¶å•ç»†èƒRNAæµ‹åºä¸­çš„å™ªå£°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRemoving unwanted variation improves accuracy in pseudobulk single-cell RNA sequencing, enhancing differential expression analysis and controlling false discoveries across challenging experimental conditions...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/controlling-noise-in-single-cell-rna-sequencing-with-pseudobulk-approaches/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ä¸€ç§é¢„é˜²ç‰™é¾ˆç–¾ç—…è€Œä¸ç ´åæœ‰ç›ŠèŒçš„æ–°æ–¹æ³•</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šbacteriaã€regex:bacter(ia|ial|ium)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists are uncovering a surprising way to influence bacteriaâ€”not by killing them, but by changing how they communicate. Researchers studying oral bacteria found that disrupting chemical signals used in bacterial â€œconversationsâ€ can shift dental plaque toward healthier, less harmful communities. The discovery could open the door to new treatments that prevent disease by maintaining a balanced microbiome rather than wiping bacteria out entirely.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251215084218.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ç»“è‚ ç™Œåœ¨å¹´è½»äººä¸­å‘ç—…ç‡æ¿€å¢ï¼ŒåŒ»ç”Ÿä»¬å¯¹æ­¤æ„Ÿåˆ°æ‹…å¿§ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šCases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in this shift. New genetic tests offer hope for earlier detection, but access and awareness lag behind. Health experts say urgent action is needed to reverse the trend.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251215084232.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>immune</td>
<td>15</td>
</tr>
<tr>
<td>ç™Œç—‡</td>
<td>9</td>
</tr>
<tr>
<td>regex:intestin(e</td>
<td>al)</td>
</tr>
<tr>
<td>gut</td>
<td>6</td>
</tr>
<tr>
<td>regex:gut(-?microbiome)?</td>
<td>6</td>
</tr>
<tr>
<td>spatial</td>
<td>6</td>
</tr>
<tr>
<td>cancer</td>
<td>4</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>4</td>
</tr>
<tr>
<td>metabolic</td>
<td>4</td>
</tr>
<tr>
<td>å…ç–«</td>
<td>4</td>
</tr>
<tr>
<td>Bç»†èƒ</td>
<td>4</td>
</tr>
<tr>
<td>è‚¿ç˜¤</td>
<td>4</td>
</tr>
<tr>
<td>sequencing</td>
<td>3</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>KRAS</td>
<td>3</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>3</td>
</tr>
<tr>
<td>epigenetic</td>
<td>3</td>
</tr>
<tr>
<td>å•ç»†èƒ</td>
<td>3</td>
</tr>
<tr>
<td>æ·‹å·´</td>
<td>3</td>
</tr>
<tr>
<td>tumor</td>
<td>3</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (45æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266100" target="_blank" rel="noopener noreferrer">GSE266100 é€šè¿‡åµŒåˆæŠ—åŸå—ä½“åè°ƒè‚¿ç˜¤æŠ—åŸæ‘„å–å’Œæ ‘çªçŠ¶ç»†èƒæ´»åŒ–ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300200" target="_blank" rel="noopener noreferrer">GSE300200 èµ–æ°¨é…¸å»ç”²åŸºé…¶ Kdm4C æ˜¯ä¸€ç§è‡´ç™Œé©±åŠ¨å› å­ï¼Œå¹¶åœ¨ KRAS çªå˜å‹èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­è°ƒèŠ‚ ERK æ´»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289850" target="_blank" rel="noopener noreferrer">GSE289850 çŠ¬æ·‹å·´ç˜¤ç—…ä¾‹å…¨è¡€ç»†èƒçš„å…¨åŸºå› ç»„äºšç¡«é…¸æ°¢ç›æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314028" target="_blank" rel="noopener noreferrer">GSE314028 æ—©æœŸ NADâº ç¼ºä¹é€šè¿‡è¡¨è§‚é—ä¼ ä¸‹è°ƒé€æ˜è´¨é…¸åˆæˆæ¥è°ƒæ§éª¨éª¼è‚Œè¡°è€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307561" target="_blank" rel="noopener noreferrer">GSE307561 Dis3l2 ä»‹å¯¼çš„ RNA ç›‘è§†å’Œç»†èƒå¤–å›Šæ³¡åŒ…è£…å¯é˜²æ­¢å¼‚å¸¸ç»†èƒ RNA æ¿€æ´»å…ˆå¤©å…ç–« [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303185" target="_blank" rel="noopener noreferrer">GSE303185 ä¸‹ä¸˜è„‘å®¤æ—ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°±ï¼ˆ10X Chromium vâ€‹â€‹3ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303083" target="_blank" rel="noopener noreferrer">GSE303083 ä¸‹ä¸˜è„‘å®¤æ—ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°±ï¼ˆ10X Chromium vâ€‹â€‹3 å¤šé‡åˆ†æï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291833" target="_blank" rel="noopener noreferrer">GSE291833 åŸºäºè½¬å½•ç»„å­¦çš„è‚ç»†èƒç™Œç­›é€‰å’Œæ–°å‹åŒ–åˆç‰©</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313929" target="_blank" rel="noopener noreferrer">GSE313929 Bç»†èƒå—ä½“ç±»åˆ«è½¬æ¢å¯¹æ·‹å·´ç˜¤ç»†èƒçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313548" target="_blank" rel="noopener noreferrer">GSE313548 å°äºèƒé¾„å„¿è¿½èµ¶æ€§ç”Ÿé•¿è¿‡ç¨‹ä¸­ä»£è°¢ç‰¹å¾çš„å¤šç»„å­¦åˆ†æåŠHBEGFä»‹å¯¼çš„ä»£è°¢è°ƒæ§æœºåˆ¶éªŒè¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313218" target="_blank" rel="noopener noreferrer">GSE313218 ç¼ºæ°§å¢å¼ºçš„è¶³è›‹ç™½å®šä¹‰çš„è‚¿ç˜¤å¯å¡‘æ€§é©±åŠ¨CCR7ä»‹å¯¼çš„ä¹³è…ºç™Œæ·‹å·´è½¬ç§»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311637" target="_blank" rel="noopener noreferrer">GSE311637 PHF8 åœ¨ç¥ç»å‘ç”Ÿè¿‡ç¨‹ä¸­å¯¹ä¸æ°¨é…¸ç”Ÿç‰©åˆæˆçš„è¡¨è§‚é—ä¼ è°ƒæ§ [ChIP-Seq H3K9me3]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308660" target="_blank" rel="noopener noreferrer">GSE308660 æ–¯ç“¦å°”å·´å²©é›·é¸Ÿå…‰å‘¨æœŸæ—¶é—´æµ‹é‡ç›¸å…³ç»„ç»‡ä¸­VAè§†è›‹ç™½è½¬å½•æœ¬å˜ä½“çš„å·®å¼‚è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283228" target="_blank" rel="noopener noreferrer">GSE283228 å·¥ç¨‹åŒ–å»æ ¸é—´å……è´¨å¹²ç»†èƒè°ƒèŠ‚å…ç–«å¾®ç¯å¢ƒå¹¶ä¿ƒè¿›ä¼¤å£æ„ˆåˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE229124" target="_blank" rel="noopener noreferrer">GSE229124 ä¸Šçš®ç»†èƒWNTåˆ†æ³Œé©±åŠ¨èƒƒç™Œçš„å¾®ç¯å¢ƒé€ƒé€¸</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312125" target="_blank" rel="noopener noreferrer">GSE312125 ä½“å†… CRISPR ç­›é€‰é‰´å®šå‡º SAGA å¤åˆç‰©æˆå‘˜æ˜¯é€ è¡€çš„å…³é”®è°ƒèŠ‚å› å­ [scRNA]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311765" target="_blank" rel="noopener noreferrer">GSE311765 ä½“å†…ç­›é€‰æ­ç¤ºäº† Hippo é€šè·¯ç»„åˆ†åœ¨å‘è‚²å’Œå†ç”Ÿä¸­çš„ç‰¹å®šä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311378" target="_blank" rel="noopener noreferrer">GSE311378 åˆ©ç”¨ Trikine å…ç–«ç–—æ³•ä»ç»†èƒè¡¨é¢é‡å¡‘ STAT ä¿¡å·é€šè·¯ [IL21 Trikine çš„ RNA æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309905" target="_blank" rel="noopener noreferrer">GSE309905 PTEN è°ƒèŠ‚è¿·èµ°ç¥ç»-èƒ°å²›ç´ ä¿¡å·ä¼ å¯¼ä»¥ä¼˜åŒ–è‡ªä¸»ç¥ç»è¾“å‡ºï¼Œä»è€Œå†³å®šå¤–å‘¨ç‚ç—‡å’Œä»£è°¢ç¨³æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307560" target="_blank" rel="noopener noreferrer">GSE307560 Dis3l2 ä»‹å¯¼çš„ RNA ç›‘è§†å’Œç»†èƒå¤–å›Šæ³¡åŒ…è£…å¯é˜²æ­¢å¼‚å¸¸ç»†èƒ RNA æ¿€æ´»å…ˆå¤©å…ç–« [miRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307559" target="_blank" rel="noopener noreferrer">GSE307559 Dis3l2 ä»‹å¯¼çš„ RNA ç›‘è§†å’Œç»†èƒå¤–å›Šæ³¡åŒ…è£…å¯é˜²æ­¢å¼‚å¸¸ç»†èƒ RNA æ¿€æ´»å…ˆå¤©å…ç–« [TGIRT-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307558" target="_blank" rel="noopener noreferrer">GSE307558 Dis3l2 ä»‹å¯¼çš„ RNA ç›‘è§†å’Œç»†èƒå¤–å›Šæ³¡åŒ…è£…å¯é˜²æ­¢å¼‚å¸¸ç»†èƒ RNA æ¿€æ´»å…ˆå¤©å…ç–« [THP TGIRT-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303256" target="_blank" rel="noopener noreferrer">GSE303256 ä¸‹ä¸˜è„‘å®¤æ—ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303082" target="_blank" rel="noopener noreferrer">GSE303082 ä¸‹ä¸˜è„‘å®¤æ—ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°± (DroNc-Seq)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303081" target="_blank" rel="noopener noreferrer">GSE303081 ä¸‹ä¸˜è„‘å®¤æ—ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°±ï¼ˆSmart-Seq2ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303080" target="_blank" rel="noopener noreferrer">GSE303080 ä¸‹ä¸˜è„‘å®¤æ—æ ¸ç»†èƒç±»å‹çš„ç©ºé—´å’ŒæŠ•å½±è½¬å½•ç»„å›¾è°±ï¼ˆDrop-Seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291190" target="_blank" rel="noopener noreferrer">GSE291190 åŸºäºè½¬å½•ç»„å­¦çš„ç‰¹å‘æ€§è‚ºçº¤ç»´åŒ–è¯ç‰©å†åˆ©ç”¨ç­›é€‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274297" target="_blank" rel="noopener noreferrer">GSE274297 NADS åŸºå› æ•²é™¤å°é¼ éª¨éª¼è‚Œçš„ç»¼åˆè½¬å½•ç»„åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313882" target="_blank" rel="noopener noreferrer">GSE313882 é€šè¿‡é…µæ¯ä»£è°¢å·¥ç¨‹é˜æ˜å—éé†‰èŒ„ä¸­é†‰èŒ„å†…é…¯ç”Ÿç‰©åˆæˆç›¸å…³çš„åŸºå› ç°‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277188" target="_blank" rel="noopener noreferrer">GSE277188 è§£ç è„‚è‚ªç»†èƒåˆ†åŒ–å’Œå»åˆ†åŒ–ä¸­çš„ YAP/TAZâ€“PPARÎ³ è°ƒæ§è½´ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252503" target="_blank" rel="noopener noreferrer">GSE252503 è§£ç  YAP/TAZâ€“PPARÎ³ è°ƒæ§è½´åœ¨è„‚è‚ªç»†èƒåˆ†åŒ–å’Œå»åˆ†åŒ–ä¸­çš„ä½œç”¨ [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248364" target="_blank" rel="noopener noreferrer">GSE248364 è§£ç  YAP/TAZâ€“PPARÎ³ è°ƒæ§è½´åœ¨è„‚è‚ªç»†èƒåˆ†åŒ–å’Œå»åˆ†åŒ–ä¸­çš„ä½œç”¨ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313585" target="_blank" rel="noopener noreferrer">GSE313585 Lcariin é€šè¿‡ä¿ƒè¿› TFEB ä¾èµ–æ€§çº¿ç²’ä½“æ¸…é™¤å’Œä»£è°¢é‡ç¼–ç¨‹æ¥æ”¹å–„è¿åŠ¨å¼•èµ·çš„ç–²åŠ³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313312" target="_blank" rel="noopener noreferrer">GSE313312 é€šè¿‡æ•è·å’Œä¿®å¤çº³ç±³è¯ç‰©æ¢å¤å°èƒ¶è´¨ç»†èƒæº¶é…¶ä½“ç¨³æ€æ²»ç–—é˜¿å°”èŒ¨æµ·é»˜ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313250" target="_blank" rel="noopener noreferrer">GSE313250 ç³–çš®è´¨æ¿€ç´ -Fasè½´æ§åˆ¶è½¬ç§»æ’­æ•£è¿‡ç¨‹ä¸­çš„å…ç–«é€ƒé€¸ [CUT&amp;Run_4T1-Dex]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313249" target="_blank" rel="noopener noreferrer">GSE313249 ç³–çš®è´¨æ¿€ç´ -Fasè½´æ§åˆ¶è½¬ç§»æ’­æ•£è¿‡ç¨‹ä¸­çš„å…ç–«é€ƒé€¸ [RNAseq_4T1-tdTomato]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313245" target="_blank" rel="noopener noreferrer">GSE313245 ç³–çš®è´¨æ¿€ç´ -Fasè½´æ§åˆ¶è½¬ç§»æ’­æ•£è¿‡ç¨‹ä¸­çš„å…ç–«é€ƒé€¸ [scRNAseq_4T1-GFPThy11]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313243" target="_blank" rel="noopener noreferrer">GSE313243 ç³–çš®è´¨æ¿€ç´ -Fas è½´æ§åˆ¶è½¬ç§»æ’­ç§æœŸé—´çš„å…ç–«é€ƒé¿ [scRNAseq_4T1-tdTomato-cTAT-zsGreen]ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313241" target="_blank" rel="noopener noreferrer">GSE313241 ç³–çš®è´¨æ¿€ç´ -Fasè½´æ§åˆ¶è½¬ç§»æ’­æ•£è¿‡ç¨‹ä¸­çš„å…ç–«é€ƒé€¸ [RNAseq_4T1-GFP]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313045" target="_blank" rel="noopener noreferrer">GSE313045 é€šè¿‡CBP/p300æŠ‘åˆ¶å®ç°é»˜å…‹å°”ç»†èƒç™Œçš„è¯ç†å­¦é€†è½¬</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308512" target="_blank" rel="noopener noreferrer">GSE308512 ALFQä½å‰‚HIV-1åŒ…è†œè›‹ç™½ç–«è‹—å¯åœ¨éäººçµé•¿ç±»åŠ¨ç‰©ä¸­è¯±å¯¼æŒä¹…çš„åŠŸèƒ½æ€§æŠ—ä½“å’Œç»†èƒååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296528" target="_blank" rel="noopener noreferrer">GSE296528 ç¥ç»å‘ç”Ÿè¿‡ç¨‹ä¸­PHF8å¯¹ä¸æ°¨é…¸ç”Ÿç‰©åˆæˆçš„è¡¨è§‚é—ä¼ è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284762" target="_blank" rel="noopener noreferrer">GSE284762 è‰¾æ»‹ç—…æ¯’æ„ŸæŸ“è€…è‚ é“å±éšœå—æŸçš„æ¢å¤èƒ½åŠ›</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284761" target="_blank" rel="noopener noreferrer">GSE284761 HIVæ„ŸæŸ“è€…è‚ é“å±éšœå—æŸå¯¹ç ´åçš„æ¢å¤èƒ½åŠ›[å›è‚ ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284755" target="_blank" rel="noopener noreferrer">GSE284755 HIVæ„ŸæŸ“è€…è‚ é“å±éšœå—æŸå¯¹ç ´åçš„æ¢å¤èƒ½åŠ›[ç»“è‚ ]</a></li>
</ul>
</div>
</details>

<details>
<summary><a name="æ›´å¤š-æœŸåˆŠæ–‡ç« "></a>ğŸ”¬ æœŸåˆŠæ–‡ç«  å…¶ä»–å†…å®¹ (9æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="https://m.x-mol.com/paper/1998508548482912256/t" target="_blank" rel="noopener noreferrer">ä¸€ä¸ªè®©æ‚£è€…å’Œå…¬ä¼—å‚ä¸åŸºç¡€ç™Œç—‡ç ”ç©¶çš„æ–°æ¡†æ¶ã€‚</a></li>
<li><a href="https://m.x-mol.com/paper/1998508558209503232/t" target="_blank" rel="noopener noreferrer">N6-Methyladenosineï¼šä½œä¸ºç™Œç—‡ä¸­æ¢è°ƒæ§å› å­çš„ RNA ä¿®é¥°ã€‚</a></li>
<li><a href="https://m.x-mol.com/paper/1998507488594874368/t" target="_blank" rel="noopener noreferrer">æ„ŸçŸ¥æ­§è§†å’Œç¤¾ä¼šäººå£å­¦å¯¹ä¹³è…ºç™Œç—‡çŠ¶è´Ÿæ‹…ä¸­ç§æ—å·®å¼‚çš„æ½œåœ¨ä½œç”¨ã€‚</a></li>
<li><a href="https://m.x-mol.com/paper/1999922989546782720/t" target="_blank" rel="noopener noreferrer">é«˜çº§æ³Œå°¿ç³»ç»Ÿç™Œç—‡å…±è¯†ä¼šè®®ï¼ˆAUC3ï¼‰2025ï¼šå…³äºè‚¾ç»†èƒç™Œå’Œå°¿è·¯ç™Œç®¡ç†çš„ä¸“å®¶å…±è¯†</a></li>
<li><a href="https://m.x-mol.com/paper/1998880583648985088/t" target="_blank" rel="noopener noreferrer">ä»‹å…¥è‚¿ç˜¤å­¦ï¼šä¸´åºŠåŒ»ç”Ÿå…³äºæ¶ˆèå’Œæ “å¡åœ¨å®ä½“è‚¿ç˜¤ä¸­ä½œç”¨çš„å…¥é—¨æŒ‡å—</a></li>
<li><a href="https://m.x-mol.com/paper/1999922991698460672/t" target="_blank" rel="noopener noreferrer">æ™šæœŸæ³Œå°¿ç™Œç—‡çš„å…±è¯†ä¸äº‰è®®ï¼š2025 å¹´é«˜çº§æ³Œå°¿ç³»ç»Ÿç™Œç—‡å…±è¯†ä¼šè®®ï¼ˆAUC3ï¼‰çš„è§è§£</a></li>
<li><a href="https://m.x-mol.com/paper/2000679417958023168/t" target="_blank" rel="noopener noreferrer">2008-2017 å¹´éæ´²ã€äºšæ´²ã€æ‹‰ä¸ç¾æ´²å’ŒåŠ å‹’æ¯”åœ°åŒºå„¿ç«¥ç™Œç—‡å­˜æ´»ç‡ï¼ˆSURVCAN-3ï¼‰ï¼šä¸€é¡¹åŸºäºäººå£çš„åŸºå‡†ç ”ç©¶ï¼Œæ¶µç›– 16,821 åå„¿ç«¥ã€‚</a></li>
<li><a href="https://m.x-mol.com/paper/2000978291939524608/t" target="_blank" rel="noopener noreferrer">ä¸‰ç»´ç™Œç—‡æˆåƒä¸­çš„å®é™…æƒè¡¡</a></li>
<li><a href="https://m.x-mol.com/paper/2001047620366286848/t" target="_blank" rel="noopener noreferrer">å¼¥åˆç™Œç—‡é¸¿æ²Ÿï¼šç¾å›½å…¬å¹³çš„æ”¿ç­–ä¸ç»“æ„æ€§è§£å†³æ–¹æ¡ˆ</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-17 21:39</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>